1-2 of 2
John Moore
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Early cessation of calcineurin inhibitors is feasible post–haploidentical blood stem cell transplant: the ANZHIT 1 study

Clinical Trials & Observations
John Moore, Nada Hamad, David Gottlieb, Ashish Bajel, David Ritchie, David Yeung, Matthew Greenwood, Duncan Purtill, Steven Tran, Annie Solterbeck, Donna Aarons, John Kwan
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5554–5565.
https://doi.org/10.1182/bloodadvances.2023009840
Published: 2023
Includes: Supplemental data
Journal Articles

Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases

Clinical Trials & Observations
John A. Snowden, Manuela Badoglio, Myriam Labopin, Sebastian Giebel, Eoin McGrath, Zora Marjanovic, Joachim Burman, John Moore, Montserrat Rovira, Nico M. Wulffraat, Majid Kazmi, Raffaella Greco, Emilian Snarski, Tomas Kozak, Kirill Kirgizov, Tobias Alexander, Peter Bader, Riccardo Saccardi, Dominique Farge
Journal: Blood Advances
Blood Adv (2017) 1 (27): 2742–2755.
https://doi.org/10.1182/bloodadvances.2017010041
Published: 2017
Includes: Supplemental data